1. In the first 2 cycles of use. Robinson JE, et al. Fertility and Sterility (2007) 87: 329-334
2. In a study of 87 women, 4 or more fertile days were identified in 80% of cycles using actual cycle length.

Primary Care Women’s Health Forum Meeting

08/11/2017

The Met Hotel, Leeds, 8th November 2017

Do your patients have questions about Clearblue Products?
Do you know the difference between our ovulation tests?
Do you know how accurate our pregnancy tests are?
Come along and meet us at our stand at PCWHF and let us help you to help your patients!
We look forward to seeing you there!

Women’s experiences of ovulation testing: a qualitative analysis

08/02/2016

Reproductive Health Journal

This new publication summarises exit interviews conducted on women who participated in a randomised controlled trial observing levels of stress while trying to conceive. The telephone interviews sought to gain feedback on women’s experiences of using the Clearblue Digital Ovulation Test.

Clearblue Fertility and Ovulation tests are different and work in different ways

British Fertility Society Annual Meeting 2014

26/11/2013

January 8th-9th, Sheffield, UK
The Mercure Hotel, Sheffield

Clearblue will be attending BFS Annual Meeting. Come and talk to us about the launch of our new Clearblue Digital Ovulation Test with Dual Hormone Indicator which identifies a wider fertile window than any other ovulation test for more opportunities to get pregnant naturally. We look forward to welcoming you to our stand.

Visit Clearblue at the Association of Early Pregnancy Units (AEPU) Annual Conference

30/10/2013

October 14-15, Leeds, UK
The Marriott Hotel

Come and talk to us about the launch of our new Clearblue Digital Ovulation Test with Dual Hormone Indicator which identifies a wider fertile window than any other ovulation test for more opportunities to get pregnant naturally

Detection of two urinary hormones by a new home ovulation test to identify the wider fertile window: a randomised comparative laboratory study of home ovulation tests

03/07/2013

A new home ovulation test (Clearblue Dual-Hormone Digital Test) detects both the pre-ovular urinary rise in estrone-3-glucuronide (E3G) and luteinising hormone (LH). The device aims to identify a wider fertile period than other home ovulation tests. This study examines the number of fertile days detected by a variety of home ovulation tests. Click here to view the poster presented at ESHRE’s 29th Annual Meeting (London, 2013).

Stress and Ovulation Tests

05/03/2013

Results of a recent study conducted by Clearblue showed that using a test such as the Clearblue Digital Ovulation Test does not add to the stress levels of women trying to conceive. In fact, it can bring benefits to the process. In the study, published in the prestigious journal, Human Reproduction, women using digital ovulation tests to time intercourse were found to be no different in terms of stress levels than women who were trying to conceive using the NICE clinical guidelines that recommend intercourse every 2 days. Moreover, use of digital ovulation tests was seen as offering additional benefits, including an increased understanding of the individual’s menstrual cycle. This was shown to give these women reassurance and confidence in focusing conception attempts at the most optimum time in their cycle. Click here to read the full study.